Body Dysmorphic Disorder: Etiology and Pathophysiology




21.

Hanes KR. Serotonin, psilocybin, and body dysmorphic disorder: a case report. J Clin Psychopharmacol. 1996;16(2):188–9.CrossRefPubMed


22.

Barr LC, Goodman WK, Price LH. Acute exacerbation of body dysmorphic disorder during tryptophan depletion. Am J Psychiatry. 1992;149(10):1406–7.PubMed


23.

Perugi G, Giannotti D, Di Vaio S, Frare F, Saettoni M, Cassano GB. Fluvoxamine in the treatment of body dysmorphic disorder (dysmorphophobia). Int Clin Psychopharmacol. 1996;11(4):247–54.CrossRefPubMed


24.

Phillips KA, Albertini RS, Rasmussen SA. A randomized placebo-controlled trial of fluoxetine in body dysmorphic disorder. Arch Gen Psychiatry. 2002;59(4):381–8.CrossRefPubMed


25.

Phillips KA, Dwight MM, McElroy SL. Efficacy and safety of fluvoxamine in body dysmorphic disorder. J Clin Psychiatry. 1998;59(4):165–71.CrossRefPubMed


26.

Phillips KA, Najjar F. An open-label study of citalopram in body dysmorphic disorder. J Clin Psychiatry. 2003;64(6):715–20.CrossRefPubMed


27.

Marazziti D, Dell’Osso L, Presta S, Pfanner C, Rossi A, Masala I, Baroni S, Giannaccini G, Lucacchini A, Cassano GB. Platelet [3H]paroxetine binding in patients with OCD-related disorders. Psychiatry Res. 1999;89(3):223–8.CrossRefPubMed


28.

Bienvenu OJ, Samuels JF, Riddle MA, Hoehn-Saric R, Liang KY, Cullen BA, Grados MA, Nestadt G. The relationship of obsessive-compulsive disorder to possible spectrum disorders: results from a family study. Biol Psychiatry. 2000;48(4):287–93.CrossRefPubMed


29.

Phillips KA, Menard W, Fay C, Weisberg R. Demographic characteristics, phenomenology, comorbidity, and family history in 200 individuals with body dysmorphic disorder. Psychosomatics. 2005;46(4):317–25.PubMedCentralCrossRefPubMed


30.

Phillips KA, Gunderson CG, Mallya G, McElroy SL, Carter W. A comparison study of body dysmorphic disorder and obsessive-compulsive disorder. J Clin Psychiatry. 1998;59(11):568–75.CrossRefPubMed


31.

Monzani B, Rijsdijk F, Iervolino AC, Anson M, Cherkas L, Mataix-Cols D. Evidence for a genetic overlap between body dysmorphic concerns and obsessive-compulsive symptoms in an adult female community twin sample. Am J Med Genet Part B, Neuropsychiatr Genet. 2012;159B(4):376–82. (The official publication of the International Society of Psychiatric Genetics)CrossRef


32.

Neziroglu F, Khemlani-Patel S, Veale D. Social learning theory and cognitive behavioral models of body dysmorphic disorder. Body Image. 2008;5(1):28–38.CrossRefPubMed


33.

Rieves LC, TF. Social developmental factors and women’s body image attitudes. J Soc Behav Personal. 1996;1(1996):63–78.


34.

Cash TF, Winstead, BA, Janda, LH. The great American shape-up: Body image survey report. Psychol Today. 1986;20:20–37.

Apr 26, 2017 | Posted by in Dermatology | Comments Off on Body Dysmorphic Disorder: Etiology and Pathophysiology

Full access? Get Clinical Tree

Get Clinical Tree app for offline access